feed,title,long_url,short_url
SeekingAlpha,Urovant Sciences: Buyout Price Is Too Low,https://seekingalpha.com/article/4389269,
SeekingAlpha,BioMarin: An Undervalued Leader With Multiple Catalysts In 2021,https://seekingalpha.com/article/4389268,
